Renal dysfunction after treatment with isophosphamide (NSC-109724)

Cancer Chemother Rep. 1974 May-Jun;58(3):375-82.
No abstract available

MeSH terms

  • Acidosis / chemically induced
  • Alkylating Agents / adverse effects*
  • Alkylating Agents / therapeutic use
  • Amino Acids / urine
  • Blood Proteins / analysis
  • Blood Urea Nitrogen
  • Breast Neoplasms / drug therapy
  • Creatinine / urine
  • Cyclic P-Oxides / adverse effects*
  • Cyclic P-Oxides / therapeutic use
  • Ethylamines / adverse effects
  • Ethylamines / therapeutic use
  • Female
  • Glycosuria / chemically induced
  • Humans
  • Ketones / urine
  • Kidney Concentrating Ability
  • Kidney Diseases / chemically induced*
  • Kidney Function Tests
  • Kidney Glomerulus / physiopathology
  • Kidney Tubules / physiopathology
  • Middle Aged
  • Osmolar Concentration
  • Oxazines / adverse effects*
  • Oxazines / therapeutic use
  • Phosphates / urine
  • Proteinuria / chemically induced
  • Time Factors

Substances

  • Alkylating Agents
  • Amino Acids
  • Blood Proteins
  • Cyclic P-Oxides
  • Ethylamines
  • Ketones
  • Oxazines
  • Phosphates
  • Creatinine